Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis

Androgen deprivation therapy (ADT) for men with prostate cancer (PCa) results in accelerated bone loss and increased risk of bone fracture. The aim of the present study was to evaluate serum bone markers—sclerostin, Dickkopf-1 (DKK-1) and osteoprotegerin (OPG), in a cohort of 88 PCa patients without...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Alice, Karunasinghe, Nishi, Plank, Lindsay D., Zhu, Shuotun, Osborne, Sue, Brown, Charis, Bishop, Karen, Schwass, Tiffany, Tijono, Sofian, Holmes, Michael, Masters, Jonathan, Huang, Roger, Keven, Christine, Ferguson, Lynnette R., Lawrenson, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295319/
https://www.ncbi.nlm.nih.gov/pubmed/34290287
http://dx.doi.org/10.1038/s41598-021-94090-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295319/
https://www.ncbi.nlm.nih.gov/pubmed/34290287
http://dx.doi.org/10.1038/s41598-021-94090-y

Ejemplares similares